Immune tolerance induction with high von Willebrand factor/factor VIII content ratio concentrate in children with haemophilia A and high-responding inhibitor

Haemophilia

Volumn 15, Issue 2, 2009, Pages 617-619

  Platokouki, Helen ^a   Pergantou, H ^a   Xafaki, P ^a   Komitopoulou, A ^a   Aronis, S ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; RECOMBINANT BLOOD CLOTTING FACTOR 7A; RITUXIMAB; VON WILLEBRAND FACTOR;

ADD ON THERAPY; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG RESPONSE; DRUG SAFETY; DRUG TOLERABILITY; HEMOPHILIA A; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; THROMBOEMBOLISM;

BLOOD COAGULATION FACTOR INHIBITORS; CHILD; FACTOR VIII; HEMOPHILIA A; HUMANS; IMMUNE TOLERANCE; MALE; VON WILLEBRAND FACTOR;

EID: 63349112118     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2008.01965.x     Document Type: Article

References (5)

1. DiMichele DM, Hoots WK, Pipe SW, Rivard GE, Santagostino E. International workshop on immune tolerance induction: Consensus recommendations. Haemophilia 2007; 13(Suppl 1): 1-22.
2. Wight J, Paisley S, Knight C. Immune tolerance induction in patients with haemophilia A with inhibitors: A systematic review. Haemophilia 2003; 9: 436-63.
3. DiMichele DM. Immune tolerance: A synopsis of the international experience. Haemophilia 1998; 2: 863-5.
4. Kreutz W, Escuriola-Ettingshausen C, Auerswald G. Immune tolerance induction in haemophilia A patients with inhibitors: The choice of concentrate affecting success. Haematologica 2003; 86 (Suppl 4): 16-20.
5. Rodriguez NI, Hoots WK. Advances in Hemophilia: Experimental aspects and therapy. Paediatric Clinics of North America 2008; 55: 357-76.